Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research.
Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research.
复制标题
DOI：
10.1177/1527154410365563
复制
发表时间：
2010-03
期刊：
影响因子：
--
通讯作者：
Botkin J
中科院分区：
文献类型：
--
作者：
Rothwell E;Anderson R;Botkin J
Newborn screening is an important public health programs in the United States. Over 4 million infants are screened each year for a number of conditions. There is a growing need for more explicit state policies governing the storage and research use of residual newborn samples. This paper provides an overview of newborn screening and issues related to policies of residual newborn samples as well as attitudes and opinions from stakeholders. Three groups (n = 21) were conducted with stakeholders: an African American group, a Pediatrician group and a Mothers of young children group. Despite the differences between these groups, consistent themes emerged from all groups that may be relevant for policy development governing the storage and use of residual newborn samples. The data from this exploratory study suggest that future policy developments with the newborn screening program warrant further public input on these topics.
